Accordingly, PTX3 levels are significantly increased in patients with carotid stenosis [25], as well as in patients with acute coronary syndrome [26], in whom PTX3 is a candidate biomarker for plaque vulnerability [27]. This evidence concerns the gene PTX3 and acute coronary syndrome.